Nusano
Kevin Haehl is an accomplished professional in the pharmaceutical and biotech industries with extensive experience in product and development leadership. Currently serving as Chief Product Officer at Nusano and prior as Chief Development Officer at Nucleus Radiopharma, Haehl has held significant roles including Site Head at Novartis and Senior Director of CMC at Advanced Accelerator Applications. In addition to industry roles, Haehl contributes to education as an Adjunct Faculty member at Ivy Tech Community College. Haehl holds a Bachelor of Science in Chemical Engineering from Purdue University, graduating with Highest Distinction in 1989.
This person is not in any teams
This person is not in any offices
Nusano
2 followers
Nusano is a private company that intends to bring stability to the underserved market of radioisotopes. With the help of a high-current ion source and linear accelerator, Nusano can now produce radioisotopes with no more restrictions for use in medicine and other innovative applications. The facility will include complete cGMP radioisotopemanufacturing processing.